Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr792 Activators

Olfr792 is a member of the olfactory receptor family, a group of G protein-coupled receptors (GPCRs) essential for the sense of smell. These receptors, including Olfr792, are specialized for detecting odorant molecules. The typical activation of such receptors involves ligand binding, leading to conformational changes in the receptor. This change facilitates the interaction with G proteins, initiating a series of intracellular signaling events. The exact ligands and broader physiological roles of Olfr792 are still being explored, reflecting the complexity and diversity within the olfactory system and GPCR-mediated signaling. The activation of Olfr792, as with other GPCRs, is influenced by a range of factors within the cellular environment. A critical element in GPCR regulation is the cyclic adenosine monophosphate (cAMP) signaling pathway. cAMP acts as a second messenger involved in numerous cellular functions, including the regulation of GPCR signaling. The production of cAMP is regulated by adenylate cyclase, which converts ATP to cAMP in response to various stimuli. The resultant cAMP can activate protein kinase A (PKA), leading to the phosphorylation of target proteins, including GPCRs. This phosphorylation can influence the receptor's sensitivity to its ligands and its overall responsiveness. Additionally, cAMP can interact with other signaling pathways that intersect with GPCR signaling, thereby modulating the activity of receptors like Olfr792.

Phosphodiesterases (PDEs) are enzymes that play a vital role in regulating cAMP levels by catalyzing its breakdown. Inhibiting these enzymes can lead to increased cAMP within the cell, indirectly affecting GPCR signaling, including the pathways associated with Olfr792. Chemicals that inhibit PDEs, resulting in elevated cAMP levels, can indirectly modulate the activity of Olfr792 through changes in receptor phosphorylation, ligand-receptor interactions, and receptor-G protein coupling. Additionally, compounds that directly increase cAMP levels, such as adenylate cyclase activators or β-adrenergic receptor agonists, can also indirectly influence the activity of Olfr792. These interactions highlight the intricate regulation of GPCRs and underscore the potential of various chemical compounds to modulate the activity of receptors like Olfr792 indirectly. In conclusion, understanding the activation of Olfr792 provides insights into the complex interplay of various cellular components and signaling molecules. This knowledge is crucial for advancing our understanding of olfactory receptors and their roles in physiological and sensory processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Isoproterenol, a synthetic catecholamine and β-adrenergic agonist, elevates intracellular cAMP via adenylate cyclase activation. This cAMP increase could indirectly modulate Olfr792 signaling pathways, enhancing receptor activation and signal transduction.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

3-Isobutyl-1-methylxanthine (IBMX), a non-selective phosphodiesterase inhibitor, enhances cAMP and cGMP levels. This elevation may indirectly influence Olfr792 by modulating GPCR signaling pathways, altering receptor dynamics and signaling efficacy.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

Epinephrine, an endogenous catecholamine, stimulates α and β-adrenergic receptors, increasing cAMP via adenylate cyclase. This cAMP surge could indirectly affect Olfr792 activation, potentially enhancing its activity through downstream signaling cascades.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Rolipram selectively inhibits phosphodiesterase 4 (PDE4), leading to increased cAMP levels. Elevated cAMP may enhance Olfr792 activity by modulating intersecting GPCR signaling pathways, altering receptor dynamics and downstream signaling.

Cilostamide (OPC 3689)

68550-75-4sc-201180
sc-201180A
5 mg
25 mg
$92.00
$357.00
16
(1)

Cilostamide, a selective PDE3 inhibitor, raises intracellular cAMP, potentially influencing Olfr792 activation by affecting GPCR-mediated signaling pathways, possibly through receptor trafficking or signaling efficiency changes.

Salbutamol

18559-94-9sc-253527
sc-253527A
25 mg
50 mg
$94.00
$141.00
(1)

Salbutamol, a β2-adrenergic agonist, increases cAMP levels via adenylate cyclase activation. This rise might boost Olfr792 activity by impacting GPCR-linked pathways, potentially enhancing receptor activation and signal transduction.

Theophylline

58-55-9sc-202835
sc-202835A
sc-202835B
5 g
25 g
100 g
$20.00
$32.00
$85.00
6
(0)

Theophylline, a non-selective phosphodiesterase inhibitor, increases cAMP and cGMP levels. Elevated cAMP might stimulate Olfr792 by influencing associated GPCR signaling pathways, potentially affecting receptor conformation and signaling.

Dobutamine

34368-04-2sc-507555
100 mg
$295.00
(0)

Dobutamine, a synthetic catecholamine, targets β1-adrenergic receptors, increasing cAMP. This elevation could modulate Olfr792 activity by affecting GPCR-mediated signaling pathways, leading to changes in receptor activation dynamics.

Milrinone

78415-72-2sc-201193
sc-201193A
10 mg
50 mg
$165.00
$697.00
7
(0)

Milrinone, a selective PDE3 inhibitor, enhances cAMP levels, potentially influencing Olfr792 activation by affecting related GPCR signaling pathways, modifying receptor responsiveness and signaling efficacy.